Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kitron Board/Management Information 2019

Jun 6, 2019

3643_rns_2019-06-06_c7fdae17-bafc-49f2-af61-db9230444b66.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Kitron: CEO Peter Nilsson to resume his duties on 30 September 2019

Kitron: CEO Peter Nilsson to resume his duties on 30 September 2019

(2019-06-06) Reference is made to Kitron's stock exchange notice on 3 January

about CEO Peter Nilsson going on medical leave until the end of June 2019 for

cancer treatment.

The treatment has progressed according to the plan and is in its final phases.

The medical leave will be extended until the last treatment phase is concluded

by the end of September, and Mr. Nilsson is expected to resume his duties as

Kitron CEO on 30 September 2019.

CFO Cathrin Nylander will continue in her role as acting CEO.

For further information, please contact:

Cathrin Nylander, CFO and acting CEO, tel: +47 900 43 284

E-mail: [email protected] (mailto:[email protected])

Kitron is one of Scandinavia's leading electronics manufacturing services

companies for the Energy/Telecoms, Industry, Defence/Aerospace, Medical devices

and Offshore/Marine sectors. The company is located in Norway, Sweden,

Lithuania, Germany, China and the United States. Kitron had revenues of about

NOK 2.6 billion in 2018 and has about 1,700 employees. www.kitron.com

(http://www.kitron.com)

This information is subject to the disclosure requirements set out in section

5-12 of the Norwegian Securities Trading Act, and section 3-4 of the Oslo Stock

Exchange continuing obligations for listed companies.